American Red Cross Donor And Client Support Center – FDA 483, Oct 29, 2010

This FDA Form 483 documents significant deficiencies at the American Red Cross's (ARC) Donor Client Support Center (DCSC) in Philadelphia, Pennsylvania, and Charlotte, North Carolina, following the consolidation of donor management activities from 35 regional offices between May 2008 and March 2010.

The primary violation cited is ARC's failure to comply with Paragraph IV of the Amended Consent Decree of Permanent Injunction (April 15, 2003), which mandates establishing and maintaining adequate methods, facilities, systems, and controls to prevent the collection, manufacture, processing, packing, holding, or distribution of adulterated, misbranded, or otherwise non-compliant drug articles.

Key observations include: - **Chronic Understaffing and Lack of Process Controls:** Internal audits and assessments from May 2008 to March 2010 repeatedly identified chronic understaffing and inadequate process controls, leading to untimely and insufficient performance of donor management functions. - **Management Awareness and Ineffective Corrective Actions:** Senior management, including the Quality and Compliance Oversight Committee (QCOC) and Board of Governors, were aware of these issues through meeting minutes and quality reports, yet corrective actions were repeatedly promised but often incomplete or ineffective. - **Significant Backlogs:** As of April 2010, there was an approximate 18,000-case backlog of donor management cases not process verified. At the